Literature DB >> 25728520

Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian family.

I Colombo1, S Pagliarani2, S Testolin3, E Salsano4, L M Napoli3, A Bordoni2, S Salani2, E D'Adda5, L Morandi6, L Farina7, F Magri2, M Riva8, A Prelle5, M Sciacco3, G P Comi2, M Moggio3.   

Abstract

Adult Polyglucosan Body Disease (APBD) is a rare inherited leukodystrophy associated with axonal polyneuropathy, mainly reported in persons of Ashkenazi-Jewish descent. We describe three Italian siblings at disease onset, presenting in their fifties with a combination of pyramidal and ataxic signs, mild demyelinating neuropathy on neurophysiological investigation (1/3 cases) and transient symptoms (1/3). A leucoencephalopathy with infratentorial lesions without enhancement and medullary/spine atrophy was demonstrated on brain/spine MRI (3/3). Muscle biopsy was normal in 2/3; both muscle and nerve biopsy showed polyglucosan bodies in the sibling with polyneuropathy. This indicated a need for GBE1 sequencing, which revealed a novel missense mutation (c.1064G>A; p.Arg355His) and one previously described (c.1604A>G; p.Tyr535Cys) in all siblings. We highlight that peripheral neuropathy, deemed as disease hallmark, may be missing and that transient symptoms are confirmed as early disease manifestations. The pattern of damage at neuro-imaging described recurs irrespective of clinical presentation, constituting a unifying diagnostic clue.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1,4-Alpha-glucan branching enzyme; Adult Polyglucosan Body Disease; GBE1; Leukodystrophy

Mesh:

Year:  2015        PMID: 25728520     DOI: 10.1016/j.nmd.2015.01.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Adult polyglucosan body disease-an atypical compound heterozygous with a novel GBE1 mutation.

Authors:  Andreia Carvalho; Joana Nunes; Ricardo Taipa; Manuel Melo Pires; Jorge Pinto Basto; Pedro Barros
Journal:  Neurol Sci       Date:  2021-01-31       Impact factor: 3.307

2.  Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease.

Authors:  Yasuo Harigaya; Takashi Matsukawa; Yukio Fujita; Kazuyuki Mizushima; Hiroyuki Ishiura; Jun Mitsui; Shinichi Morishita; Mikio Shoji; Yoshio Ikeda; Shoji Tsuji
Journal:  Neurol Genet       Date:  2017-02-24

3.  Polyglucosan body myopathy 1 may cause cognitive impairment: a case report from China.

Authors:  Lin Chen; Nan Wang; Wenbin Hu; Xuen Yu; Renming Yang; Yongzhu Han; Yan Yan; Na Nian; Congbo Sha
Journal:  BMC Musculoskelet Disord       Date:  2021-01-07       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.